Using AI to find cancer origin from lymph node biopsy
Part of Cancer clinical trials.
This study uses computer intelligence (deep learning) to analyze cells from a lymph node biopsy to find where in the body a cancer might have started. It looks at past patient data and images to train a program that could help doctors in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a lymph node biopsy or puncture at one of the four participating hospitals (West China Hospital, First Affiliated Hospital of Zhengzhou University, Sichuan Provincial Cancer Hospital, or Cancer Hospital of the Chinese Academy of Medical Sciences).
- Your biopsy was done between October 1, 2008 and August 31, 2024 (for West China Hospital) or between January 1, 2020 and August 31, 2024 (for the other hospitals).
- Your medical records include details like your age, diagnosis, treatment, and survival time.
- Your biopsy images are clear and not blurry or damaged.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to look at ultrasound images and lymph node samples from people with thyroid cancer. The goal is to see if the AI can help predict whether cancer has spread to lymph nodes, which may guide treatment decisions.
This trial uses artificial intelligence to predict if early-stage lung cancer has spread to nearby lymph nodes. It aims to help doctors make better treatment decisions for patients with stage 1 lung cancer.
This trial uses artificial intelligence to analyze digital images of tumor tissue to see if cancer has spread to nearby lymph nodes. It aims to improve diagnosis for many types of cancer.
This study tests if artificial intelligence can predict whether early-stage stomach cancer has spread to lymph nodes. It also evaluates how well doctors assess the cancer. If the technology works, it could help guide treatment decisions.
This study uses an artificial intelligence (AI) system to look at prostate biopsy samples and predict if the cancer has spread to the lymph nodes. It may help doctors decide on the best treatment without needing extra surgery or scans.
This study tests whether a computer program can find cancer signs in CT scans that were done for other reasons (like check-ups) without needing a separate special scan. If you've already been diagnosed with breast, liver, kidney, or bladder cancer and had a CT scan before treatment, you might be able to join.
Hear when a new Lymph Nodes With Tumor Metastasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.